HCA Healthcare, Inc. $HCA Position Lifted by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,065,225 shares of the company’s stock after purchasing an additional 36,414 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.91% of HCA Healthcare worth $880,199,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. increased its stake in HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $40,000. Compound Global Advisors LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $44,000. Finally, True Wealth Design LLC lifted its holdings in HCA Healthcare by 179.5% in the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. Corporate insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on HCA shares. Oppenheimer increased their price target on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a research report on Wednesday, January 28th. Finally, Robert W. Baird raised their price target on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $537.73.

HCA Healthcare Stock Down 1.1%

HCA stock opened at $531.62 on Friday. The company has a market capitalization of $118.88 billion, a P/E ratio of 18.73, a PEG ratio of 1.65 and a beta of 1.34. The company has a 50-day simple moving average of $505.79 and a 200 day simple moving average of $468.65. HCA Healthcare, Inc. has a fifty-two week low of $311.26 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. During the same period in the prior year, the business posted $6.22 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.